Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Carrier free oral Co-delivery of atorvastatin via baicalein-copper-network for atherosclerosis therapy through senescence reversal and multi-mechanistic synergy

Bioactive Materials(2026)10.1016/j.bioactmat.2025.12.036Source: DataRank Database

Carrier free oral Co-delivery of atorvastatin via baicalein-copper-network for atherosclerosis therapy through senescence reversal and multi-mechanistic synergy is a research paper published in Bioactive Materials (2026). On theSindex it has a DataRank of 0.241. It has been cited 4 times.

N/A

0.241DataRank · unranked

Scored on demand from live citation data

4 citations

Download PDF

Cite:

Linked data & code

uniprot doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (11 grants)Impact (FWCI 23.24)OA: goldTopics (15)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.241

From this paper's citation signal

Citation Network Contribution

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (9)

Gen Li ORCID,Xiaoyu Liang,Changduo Wang ORCID,Ni Zhu,Xue Fu

Live enrichment

PubMed:41551775 PMC:PMC12809744 OpenAlex:https://openalex.org/W7118173661

National Natural Science Foundation of China

Grant: 82072080

National Natural Science Foundation of China

Grant: 82470514

Tianjin Municipal Science and Technology Committee

Grant: 24ZXZSSS00200

Chinese Academy of Medical Sciences Initiative for Innovative Medicine

Grant: 2022-I2M-3-002

Chinese Academy of Medical Sciences Initiative for Innovative Medicine

Grant: 2023-I2M-2-008

Chinese Academy of Medical Sciences Initiative for Innovative Medicine

Grant: 2021-12M-1-058

Fundamental Research Funds for the Central Universities

Grant: 3332024083

Natural Science Foundation of Tianjin Municipality

Grant: 24JCZDJC00420

Natural Science Foundation of Tianjin Municipality

Grant: 2025ZD0546100

China Postdoctoral Science Foundation

Grant: 2024M760263

Fundamental Research Funds for the Central Universities

FWCI

23.24

Citation Percentile

1.0%

Citation Trend

2026

goldLicense: cc-by-nc-nd

journalhttps://doi.org/10.1016/j.bioactmat.2025.12.036

publisherhttps://doi.org/10.1016/j.bioactmat.2025.12.036

publisherhttps://api.elsevier.com/content/article/PII:S2452199X25006279?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2452199X25006279?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/41551775

Fields of Study

Flavonoids in Medical ResearchRetinal Diseases and TreatmentsAdvanced Glycation End Products research

Keywords

AtorvastatinBioavailabilitySenescenceAntioxidantInflammationOral administrationDNA damageAtherosclerosisAnti-inflammationAnti-agingRos HomeostasisSynergistic Treatment

Sustainable Development Goals

SDG 0: Good health and well-being

Carrier free oral Co-delivery of atorvastatin via baicalein-copper-network for atherosclerosis therapy through senescence reversal and multi-mechanistic synergy

FAIR Checklist

DataRank Breakdown

Authors (9)

Funding (11 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)